TSS
MDNA

Two Sigma Securities’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Two Sigma Securities’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,092
Closed -$11.2K – 3798
2023
Q3 		$11.2K Buy
38,092
+21,706
+132% +$8.44K ﹤0.01% 2678
2023
Q2 		$7.89K Buy
16,386
+1,895
+13% +$1.17K ﹤0.01% 2625
2023
Q1 		$9.12K Sell
14,491
-21,394
-60% -$13.3K ﹤0.01% 2469
2022
Q4 		$16.4K Buy
+35,885
New +$21.9K ﹤0.01% 2296

Other funds holding MDNA

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Two Sigma Securities's MDNA Position: Q4 2023 in Review

Two Sigma Securities sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 38,092 shares — an estimated $11.2K sold.

Two Sigma Securities first reported a position in MDNA in Q4 2022 and held it in 4 quarters. The position peaked at $16.4K in Q4 2022. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

  • Two Sigma Securities reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 38,092 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $11.2K.
  • Two Sigma Securities first reported a position in Medicenna Therapeutics Corp. Common Shares in Q4 2022 and held it in 4 quarters.
  • Two Sigma Securities's Medicenna Therapeutics Corp. Common Shares position peaked at $16.4K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.